Aflac Incorporated (NYSE:AFL) Stake Trimmed by Calamos Advisors LLC

Calamos Advisors LLC lowered its stake in Aflac Incorporated (NYSE:AFL) by 1.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 136,821 shares of the financial services provider’s stock after selling 1,787 shares during the quarter. Calamos Advisors LLC’s holdings in Aflac were worth $11,288,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of AFL. Fortitude Family Office LLC purchased a new position in Aflac in the 4th quarter worth about $25,000. CoreFirst Bank & Trust acquired a new stake in Aflac during the 4th quarter worth about $25,000. Studio Investment Management LLC acquired a new stake in Aflac during the 4th quarter worth about $27,000. Impact Partnership Wealth LLC boosted its position in Aflac by 471.4% during the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 330 shares during the period. Finally, Bruce G. Allen Investments LLC acquired a new stake in Aflac during the 4th quarter worth about $32,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Up 2.8 %

Shares of AFL stock opened at $83.23 on Friday. The stock’s 50 day simple moving average is $82.21 and its 200 day simple moving average is $81.50. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. Aflac Incorporated has a twelve month low of $64.10 and a twelve month high of $86.26. The company has a market capitalization of $47.89 billion, a price-to-earnings ratio of 10.74, a PEG ratio of 2.20 and a beta of 0.91.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. During the same period in the previous year, the business posted $1.29 earnings per share. As a group, research analysts predict that Aflac Incorporated will post 6.41 EPS for the current year.

Analyst Upgrades and Downgrades

AFL has been the subject of a number of research reports. StockNews.com lowered Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday, April 10th. UBS Group raised their price objective on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and raised their price objective for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Wells Fargo & Company decreased their price objective on Aflac from $83.00 to $81.00 and set an “equal weight” rating for the company in a research report on Thursday, April 11th. Finally, Piper Sandler raised their price objective on Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $82.15.

Insider Activity at Aflac

In related news, Director Arthur Reginald Collins sold 3,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Aflac news, Director Arthur Reginald Collins sold 3,000 shares of Aflac stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares of the company’s stock, valued at approximately $445,850.16. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Masatoshi Koide sold 30,493 shares of Aflac stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the transaction, the director now directly owns 86,090 shares in the company, valued at $6,879,451.90. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 46,493 shares of company stock valued at $3,765,706. Corporate insiders own 0.90% of the company’s stock.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.